Certified by Founder Lodge
Renibus Therapeutics Inc
United States - Southlake, Texas
START UP
1 Disclosed Funding Rounds $47,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Renibus is a clinical stage biopharmaceutical company dedicated to treating, improving and extending patients’ lives by developing breakthrough products to prevent disease progression, improv
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| July, 19 ,2023 | Series B | $47,000,000 | |
| September, 13 ,2023 | Series B | Undisclosed Amount |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Mondra | $13,206,500 | (Oct 30, 2025)
Sparrow BioAcoustics | $10,000,000 | (Oct 30, 2025)
Vesence | $9,000,000 | (Oct 30, 2025)
Homecourt | $8,000,000 | (Oct 30, 2025)
Reflectiz | $22,000,000 | (Oct 30, 2025)
